William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
RiverGlade Capital Welcomes Jim Hudak and Dan Skowronski
-
Celyad SA (CYAD) Names Filippo Petti as CFO
-
Celyad Appoints Filippo Petti as Chief Financial Officer
-
Celyad Appoints Filippo Petti as Chief Financial Officer
-
CAI International, Inc. Announces Pricing of Public Offering of Series B Preferred Stock
-
NeoGenomics (NEO) Announces $125M Proposed Public Offering of Common Stock
-
NeoGenomics Announces Proposed Public Offering of Common Stock
-
NeoGenomics Announces Proposed Public Offering of Common Stock
-
Cushman & Wakefield Announces Closing of its Initial Public Offering of Ordinary Shares
-
Warburg Pincus Invests in Procare Software®
-
Pre-Open Movers 08/06: (SEAS) (VTL) (CTWS) Higher; (OVID) (BID) (PX) Lower (more...)
-
CAI International, Inc. Announces Public Offering of Series B Preferred Stock
-
UPDATE: William Blair Upgrades Vital Therapies (VTL) to Outperform
-
Restoration Robotics (HAIR) Announces Proposed $25M Common Share Offering
-
Restoration Robotics™ Announces Proposed Public Offering of Common Stock
-
Acer Therapeutics Announces Closing of Underwritten Public Offering
-
William Blair Downgrades Titan International (TWI) to Market Perform
-
William Blair Downgrades Navigant Consulting (NCI) to Market Perform Citing 2019 Uncertainty
-
Cushman & Wakefield (CWK) IPO Opens 6% Higher
-
Cushman & Wakefield plcPrices 45M Share IPO at $17/Sh
-
Cushman & Wakefield Announces Pricing of its Initial Public Offering of Ordinary Shares
-
CyrusOne Reports Second Quarter 2018 Earnings
-
Acer Therapeutics (ACER) Prices 2.22M Share Common Offering at $18/Sh
-
Acer Therapeutics Announces Pricing of Underwritten Public Offering
-
Analysis Group Announces Recent Promotions and Welcomes a New Consultant and Affiliates
-
Bertram Capital Completes Sale of PMC to SIMONA Group
-
Acer Therapeutics (ACER) to Offer Common Stock
-
Endava Announces Closing of Initial Public Offering
-
Acer Therapeutics Announces Underwritten Public Offering
-
William Blair Downgrades Blackbaud (BLKB) to Market Perform
-
William Blair Upgrades Medpace (MEDP) to Outperform
-
Tenable Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Starbucks and China's Alibaba to partner on delivery: media reports
-
Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Premier Research Acquires California-Based Regulatory Professionals, Inc.
-
William Blair Remains Bullish on AbbVie (ABBV) Following 2Q Beat
-
William Blair Remains Bullish on Intuit (INTU)
-
With nimbler bikes, Harley sharpens Asia focus to revive growth
-
Endava plc (DAVA) IPO Opens 25% Higher
-
ContraFect (CFRX) Prices 5M Share Public Offering of Common Stock at $2/Sh
-
ContraFect Corporation Prices $10 Million Public Offering of Common Stock
-
Endava plc (DAVA) Prices 6.34M ADS IPO at $20/ADS
-
Endava Announces Pricing of Initial Public Offering
-
ContraFect (CFRX) Announces Proposed Common Share Offering
-
ContraFect Corporation Announces Proposed Public Offering of Common Stock
-
Focus Financial Partners (FOCS) IPO Opens 9% Higher
-
Tenable Holdings (TENB) IPO Opens 43% Higher
-
Beeline to Partner with New Mountain Capital
-
UPDATE: Tenable Holdings, Inc. (TENB) Prices 10.9M Share IPO at $23/Sh
-
Focus Financial Partners Inc. (FOCS) Prices 16.2M Class A Share IPO at $33/Sh

